Anti-TGDS antibodies are used in the immunodetection of the protein TDP-glucose 4,6-dehydratase. In humans, the canonical protein has a reported length of 350 amino acid residues and a mass of 40.2 kDa. It is notably expressed in many tissues, such as the bone marrow, vagina, and adrenal gland. A member of the NAD(P)-dependent epimerase/dehydratase protein family, TGDS is known to be involved with metabolic processes. The TGDS gene has been associated with the disease, Catel-Manzke syndrome. Synonyms for this target antigen include SDR2E1, TDPGD, dTDP-D-glucose 4,6-dehydratase, growth-inhibiting protein 21, short chain dehydrogenase/reductase family 2E, member 1, and CATMANS. TGDS gene orthologs have been reported in the mouse, bovine, frog, chimpanzee and chicken species. Western Blot is the most common application for the TGDS antibodies listed below. ELISA and Immunohistochemistry are also common applications.